Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CDK12 is hyperactivated and a synthetic-lethal target in BRAF-mutated melanoma
Thibault Houlès, Geneviève Lavoie, Sami Nourreddine, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 16

Showing 16 citing articles:

Targeting CDK1 in cancer: mechanisms and implications
Qiushi Wang, Ann M. Bode, Tianshun Zhang
npj Precision Oncology (2023) Vol. 7, Iss. 1
Open Access | Times Cited: 79
Recent Advances in Therapeutic Strategies to Improve Colorectal Cancer Treatment
William H. Gmeiner
Cancers (2024) Vol. 16, Iss. 5, pp. 1029-1029
Open Access | Times Cited: 17
Cyclin‐dependent kinase 12 deficiency reprogrammes cellular metabolism to alleviate ferroptosis potential and promote the progression of castration‐resistant prostate cancer
Haozhe Zhang, Yi Zhou, Yating Feng, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 5
Open Access | Times Cited: 6
Development of an orally bioavailable CDK12/13 degrader and induction of synthetic lethality with AKT pathway inhibition
Yu Chang, Xiaoju Wang, Jianzhang Yang, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 10, pp. 101752-101752
Open Access | Times Cited: 6
Absence of CDK12 in oocyte leads to female infertility
Denisa Jansová, Veronika Sedmikova, Fatima J. Berro, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access
Identification of RSK substrates using an analog-sensitive kinase approach
Belén Lizcano-Perret, Didier Vertommen, Gaëtan Herinckx, et al.
Journal of Biological Chemistry (2024) Vol. 300, Iss. 3, pp. 105739-105739
Open Access | Times Cited: 3
The CDK12 inhibitor SR-4835 functions as a molecular glue that promotes cyclin K degradation in melanoma
Thibault Houlès, Jonathan Boucher, Geneviève Lavoie, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 8
Paralog-based synthetic lethality: rationales and applications
Yucui Xin, Yingsheng Zhang
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 7
Repurposing of Antidiarrheal Loperamide for Treating Melanoma by Inducing Cell Apoptosis and Cell Metastasis Suppression In Vitro and In Vivo
Shuping Yang, Zhi Li, Mingyue Pan, et al.
Current Cancer Drug Targets (2024) Vol. 24, Iss. 10, pp. 1015-1030
Closed Access | Times Cited: 1
Nebivolol, an antihypertensive agent, has new application in inhibiting melanoma
Shuping Yang, Zhi Li, Jiamei Yi, et al.
Anti-Cancer Drugs (2024)
Open Access | Times Cited: 1
Differential contribution for ERK1 and ERK2 kinases in BRAFV600E-triggered phenotypes in adult mouse models
Giuseppe Bosso, Ana Carolina Cintra Herpst, Oscar Laguía, et al.
Cell Death and Differentiation (2024) Vol. 31, Iss. 6, pp. 804-819
Open Access | Times Cited: 1
Inhibition of CDK12 elevates cancer cell dependence on P-TEFb by stimulation of RNA polymerase II pause release
Zhijia Wang, Samu V. Himanen, Heidi M. Haikala, et al.
Nucleic Acids Research (2023) Vol. 51, Iss. 20, pp. 10970-10991
Open Access | Times Cited: 3
Searching Prognostic Hub Genes for the Management of Gliomagenesis through Transcriptome Profiling
Poornimaa Murali, Muthu Kumar Thirunavukkarasu, Priyanka Ramesh, et al.
Research Square (Research Square) (2024)
Open Access
New insights into the dule roles CDK12 in human cancers: mechanisms and interventions for cancer therapy
Wei Dai, Dong Xie, Hao Huang, et al.
Journal of Pharmaceutical Analysis (2024), pp. 101173-101173
Open Access
Inhibition of CDK12 elevates cancer cell dependence on P-TEFb by stimulation of RNA polymerase II pause release
Zhijia Wang, Samu V. Himanen, Heidi M. Haikala, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
The CDK12 inhibitor SR-4835 functions as a molecular glue that promotes cyclin K degradation in melanoma
Thibault Houlès, Jonathan Boucher, Geneviève Lavoie, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Page 1

Scroll to top